Authors: Bunworasate, U Arnouk, H Minderman, H O'Loughlin, KL Sait, SNJ Barcos, M Stewart, CC Baer, MR

Citation: U. Bunworasate et al., Erythropoietin-dependent transformation of myelodysplastic syndrome to acute monoblastic leukemia, BLOOD, 98(12), 2001, pp. 3492-3494

Authors: Minderman, H Wrzosek, C Cao, SS Utsugi, T Kobunai, T Yamada, Y Rustum, YM

Citation: H. Minderman et al., Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells, CANC CHEMOT, 45(1), 2000, pp. 78-84

Authors: Slocum, HK Parsons, JC Winslow, EO Broderick, L Minderman, H Toth, K Greco, WR Rustum, YM

Citation: Hk. Slocum et al., Time-lapse video reveals immediate heterogeneity and heritable damage among human ileocecal carcinoma HCT-8 cells treated with raltitrexed (ZD1694), CYTOMETRY, 41(4), 2000, pp. 252-260

Authors: Yin, MB Guo, B Vanhoefer, U Azrak, RG Minderman, H Frank, C Wrzosek, C Slocum, HK Rustum, YMN

Citation: Mb. Yin et al., Characterization of protein kinase chk1 essential for the cell cycle checkpoint after exposure of human head and neck carcinoma A253 cells to a noveltopoisomerase I inhibitor BNP1350, MOLEC PHARM, 57(3), 2000, pp. 453-459

Authors: Smeets, MEP Raymakers, RAP Vierwinden, G Pennings, AHM Boezeman, J Minderman, H de Witte, TM

Citation: Mep. Smeets et al., Idarubicin DNA intercalation is reduced by MRP1 and not Pgp, LEUKEMIA, 13(9), 1999, pp. 1390-1398

Authors: Voigt, W Matsui, S Yin, MB Burhans, WC Minderman, H Rustum, YM

Citation: W. Voigt et al., Topoisomerase-I inhibitor SN-38 can induce DNA damage and chromosomal aberrations independent from DNA synthesis, ANTICANC R, 18(5A), 1998, pp. 3499-3505